Biontech Se ADR (BNTX) Stock Price, Quote & News

Company Profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical tri...

Industry: Biotechnology

Sector: Healthcare

Phone: 49 6131 9084

Fax: 49 6131 9084

Website: www.biontech.de

Address:

An der Goldgrube 12, Mainz, Germany

LiquidThetaLEAPS Oct. 7 at 5:28 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BNTX Current Share Price: $105.28 Contracts: $BNTX January 15, 2027 $110 Calls Scale in: $15.77- $19.28 Scale out: $24.53-$31.54 Can Easily Capture: 60% ROI Blended DTE: 466 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

taxplanr Oct. 7 at 2:30 PM

Of course $BNTX $MRNA $PFE have to bury the truth or the cancer vaccines AI wouldn't work just like the C19 injections https://justthenews.com/politics-policy/coronavirus/federally-funded-researchers-bury-results-covid-vaccine-effect-liver?utm_source=mux&utm_medium=social-media&utm_campaign=social-media-autopost

1 · Reply

taxplanr Oct. 6 at 10:19 PM

Massive 8.4 million person S Korea study finds 30% increase in cancer from C19 malignantRNA bioweapons $BNTX $MRNA $PFE https://www.thegatewaypundit.com/2025/10/devastating-covid-19-vaccine-side-effect-confirmed-new/

3 · Reply

taxplanr Oct. 6 at 2:34 AM

So Ivermectin kills cancer stem cells and chemo doesn't Do you think the malignantRNA AI's designed by $BNTX $MRNA $PFE know this? 🤣 🤣 🤣 https://www.instagram.com/reel/DPY-ifHDgOu/?igsh=MWRmMnBzcDExeGhwYg==

0 · Reply

LiquidThetaLEAPS Oct. 5 at 4:12 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BNTX Current Share Price: $105.49 Contracts: $BNTX January 15, 2027 $110 Calls Scale in: $15.88- $19.41 Scale out: $24.71-$31.77 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Vikingsstrade Oct. 4 at 5:52 PM

Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve! $NAMM $GSIW $BNTX $INSM

0 · Reply

DocPharm Oct. 4 at 4:08 PM

$BNTX bought the other 💎 $CVAC for mRNA patents (waiting for conversion) Will they or $PFE buy the gem $ABUS / ROIV/ Genevant for the LNP patents ? Very plausible

1 · Reply

taxplanr Oct. 4 at 11:32 AM

$BNTX they have a large data set of failure to draw upon 🤣 🤣 🤣

0 · Reply

SweepCastApp Oct. 4 at 5:43 AM

$BNTX: Unusual Options Activity Alerted CALL flow observed 130x contracts at Strike price of $105 Exp on 10/17/2025 with Premium of $29K and showing BEARISH Sentiment

0 · Reply

taxplanr Oct. 3 at 6:58 PM

$BNTX cancer hopium not working AI hopium not working Cancer AI hopium pump for qr plummet 🤣🤣🤣

0 · Reply

BioNTech SE, InstaDeep Ltd - Special Call

Sep 23, 2025, 6:45 AM EDT - 14 days ago

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Sep 19, 2025, 11:40 AM EDT - 18 days ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

MRNA NVAX PFE

Sep 12, 2025, 1:37 PM EDT - 25 days ago

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

JNJ KVUE MRNA PFE

Sep 8, 2025, 2:01 PM EDT - 4 weeks ago

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BMY

Sep 8, 2025, 11:05 AM EDT - 4 weeks ago

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

BMY

Sep 8, 2025, 11:00 AM EDT - 4 weeks ago

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Sep 8, 2025, 7:02 AM EDT - 4 weeks ago

Pfizer, partner BioNTech say updated COVID shot shows better immune response

PFE

Sep 8, 2025, 6:45 AM EDT - 4 weeks ago

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

PFE

Sep 5, 2025, 5:13 AM EDT - 4 weeks ago

BioNTech, Duality score initial trial win with breast cancer precision drug

Aug 28, 2025, 6:20 AM EDT - 5 weeks ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY DHR GRAL ILMN IONS MRNA RGEN

Aug 27, 2025, 12:50 PM EDT - 5 weeks ago

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

PFE

Aug 7, 2025, 9:00 PM EDT - 2 months ago

CureVac settles patent dispute litigation with Pfizer and BioNTech

CVAC PFE

Aug 5, 2025, 1:36 PM EDT - 2 months ago

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

Aug 4, 2025, 1:56 PM EDT - 2 months ago

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 10:32 AM EDT - 2 months ago

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

Aug 4, 2025, 7:01 AM EDT - 2 months ago

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

Aug 4, 2025, 6:52 AM EDT - 2 months ago

BioNTech's Q2 revenues double on higher COVID vaccine sales

Aug 4, 2025, 6:45 AM EDT - 2 months ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Aug 1, 2025, 4:51 PM EDT - 2 months ago

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

MRNA PFE

Aug 1, 2025, 8:31 AM EDT - 2 months ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

Aug 1, 2025, 6:54 AM EDT - 2 months ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Aug 1, 2025, 5:59 AM EDT - 2 months ago

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

MRNA PFE

Jul 31, 2025, 7:00 AM EDT - 2 months ago

Pandemic darlings Moderna, BioNTech are now on two different paths

MRNA

Jul 25, 2025, 2:30 AM EDT - 2 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 2 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

PFE

Jul 23, 2025, 4:11 AM EDT - 2 months ago

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

PFE

Jul 21, 2025, 6:45 AM EDT - 2 months ago

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

Jul 17, 2025, 8:30 AM EDT - 2 months ago

BioNTech Announces Ryan Richardson to Step Down from the Management Board

Jul 10, 2025, 7:18 AM EDT - 3 months ago

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

MRNA PFE

Jun 16, 2025, 3:06 PM EDT - 4 months ago

5 Stocks To Ride The German Market Rally

FMS SAP

Jun 12, 2025, 11:07 AM EDT - 4 months ago

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal

CVAC

Jun 12, 2025, 7:11 AM EDT - 4 months ago

BioNTech to Buy CureVac in $1.25 Billion Deal. Both Stocks Are Rising.

CVAC

Jun 12, 2025, 7:03 AM EDT - 4 months ago

BioNTech to acquire CureVac in $1.25 billion all-stock deal

CVAC

Jun 12, 2025, 6:45 AM EDT - 4 months ago

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Jun 10, 2025, 11:50 AM EDT - 4 months ago

RFK Jr.'s firing of CDC vaccine advisors 'circumvents science' and could threaten public health, experts say

MRK MRNA PFE

Jun 10, 2025, 10:45 AM EDT - 4 months ago

Vaccine actions and policy positions under US Health Secretary Kennedy

MRNA NVAX PFE

Jun 10, 2025, 9:30 AM EDT - 4 months ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

MRNA NVAX PFE

Jun 10, 2025, 8:18 AM EDT - 4 months ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

MRNA NVAX PFE SNY

Jun 6, 2025, 7:00 AM EDT - 4 months ago

Bristol-Myers And BioNTech Deal: Good For Both Parties, But One Is The Better Investment

BMY

Jun 3, 2025, 3:34 PM EDT - 4 months ago

Healthy Returns: AstraZeneca, Pfizer, Gilead and other drugmakers release promising cancer drug data at ASCO

AZN GILD PFE AMGN BMY MRK

Jun 2, 2025, 3:50 PM EDT - 4 months ago

Bristol Myers CEO explains why he's spending billions on BioNTech deal

BMY

Jun 2, 2025, 2:51 PM EDT - 4 months ago

Pharma may face more fundamentally negative headlines ahead, says Mizuho's Jared Holz

BMY BPMC MRK SNY

Jun 2, 2025, 12:22 PM EDT - 4 months ago

Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech

BMY

Jun 2, 2025, 11:08 AM EDT - 4 months ago

Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

BMY

Jun 2, 2025, 8:46 AM EDT - 4 months ago

Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race

BMY

Jun 2, 2025, 7:42 AM EDT - 4 months ago

BioNTech Sets Cancer-Drug Deal With Bristol Myers Squibb

BMY

Jun 2, 2025, 6:50 AM EDT - 4 months ago

Bristol Myers to pay $1.5 billion upfront for BioNTech cancer drug partnership

BMY

May 27, 2025, 8:15 AM EDT - 4 months ago

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting

May 20, 2025, 9:09 AM EDT - 5 months ago

BioNTech plans up to $1.33 billion investment in the United Kingdom

LiquidThetaLEAPS Oct. 7 at 5:28 PM

0 · Reply

taxplanr Oct. 7 at 2:30 PM

1 · Reply

taxplanr Oct. 6 at 10:19 PM

3 · Reply

taxplanr Oct. 6 at 2:34 AM

0 · Reply

LiquidThetaLEAPS Oct. 5 at 4:12 AM

0 · Reply

Vikingsstrade Oct. 4 at 5:52 PM

0 · Reply

DocPharm Oct. 4 at 4:08 PM

$BNTX bought the other 💎 $CVAC for mRNA patents (waiting for conversion) Will they or $PFE buy the gem $ABUS / ROIV/ Genevant for the LNP patents ? Very plausible

1 · Reply

taxplanr Oct. 4 at 11:32 AM

$BNTX they have a large data set of failure to draw upon 🤣 🤣 🤣

0 · Reply

SweepCastApp Oct. 4 at 5:43 AM

$BNTX: Unusual Options Activity Alerted CALL flow observed 130x contracts at Strike price of $105 Exp on 10/17/2025 with Premium of $29K and showing BEARISH Sentiment

0 · Reply

taxplanr Oct. 3 at 6:58 PM

$BNTX cancer hopium not working AI hopium not working Cancer AI hopium pump for qr plummet 🤣🤣🤣

0 · Reply

nikitatrades Oct. 3 at 11:22 AM

No financial projections, but $BNTX is building an integrated AI drug discovery machine. The goal: combine off-the-shelf drugs (like its BMS-partnered antibody) with personalized mRNA vaccines. A tech-driven vision for the future of cancer treatment. 🎯 #Oncology $BNTX

0 · Reply

nikitatrades Oct. 3 at 11:22 AM

Think of $BNTX as a tech-bio platform. Its new AI model, NTV3, can read & generate DNA sequences (1M nucleotides long!) to predict disease & design therapies. This isn't just research—it's being used to develop new cancer vaccines & treatments today. 🚀 #PrecisionMedicine

0 · Reply

nikitatrades Oct. 3 at 11:22 AM

$BNTX is far more than a COVID co. Its core focus is oncology, powered by a full-scale AI engine (InstaDeep). Showcased lab-validated breakthroughs: designing antibodies (AbBFN2), nanoparticles for vaccines & supercharging cancer-targeting TCRs (50,000x affinity boost). 🧬 #AI #Biotech

0 · Reply

taxplanr Oct. 2 at 6:05 PM

The spike proteins from $BNTX $MRNA $PFE all cause cancer https://www.thekingstonreport.com/p/sars-2-spike-proteins-weaken-cancer?utm_source=post-email-title&publication_id=1103773&post_id=174796919&utm_campaign=email-post-title&isFreemail=false&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

Giletjaune Oct. 2 at 5:34 PM

$BNTX $MRNA $PFE https://media2.giphy.com/media/05wBfiXHq4U6dfHeeP/giphy.gif?cid=69f1a12dljmado63y8alky2q9jg7t7hpos6mje9dmkj9ucnr&ep=v1_gifs_gifId&rid=giphy.gif&ct=g

0 · Reply

taxplanr Oct. 2 at 1:29 PM

$BNTX $MRNA $PFE Czech data shows no benefits and many risks for malignantRNA https://kirschsubstack.com/p/the-czech-republic-dataset-provides?utm_source=post-email-title&publication_id=548354&post_id=175065892&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

taxplanr Oct. 1 at 6:38 PM

By making healthcare providers (HCPs) partially responsible for the decision to vaccinate (including pharmacists - since they insisted on it during the ACIP meeting), many providers will radically change their minds from “everyone must get a booster,” to “if you really want a booster, I can maybe refer you to another healthcare provider who can help you.” $BNTX $MRNA $PFE https://www.thekingstonreport.com/p/will-reinstating-requirements-for?utm_source=post-email-title&publication_id=1103773&post_id=174484900&utm_campaign=email-post-title&isFreemail=false&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

taxplanr Oct. 1 at 10:38 AM

UCLA Cedars-Sinai study shows Ivermectin effective in treating Breast cancer $BNTX $MRNA $PFE https://cancer.aestheticsadvisor.com/2025/05/ivermectin-immunotherapy-triple-negative-breast-cancer.html?m=1

2 · Reply

LiquidThetaLEAPS Sep. 30 at 10:16 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $BNTX Current Share Price: $98.25 Contracts: $BNTX January 15, 2027 $100 Calls Scale in: $19.48- $23.82 Scale out: $30.31-$38.97 Can Easily Capture: 60% ROI Blended DTE: 473 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

taxplanr Sep. 30 at 7:03 PM

Another mainstay of C19 bioweapon sales says No $BNTX $MRNA $PFE https://www.thekingstonreport.com/p/cdc-data-confirms-that-healthcare?utm_source=post-email-title&publication_id=1103773&post_id=174896808&utm_campaign=email-post-title&isFreemail=false&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

taxplanr Sep. 30 at 1:38 PM

$BNTX $MRNA $PFE Japan bioweapon data https://kirschsubstack.com/p/japan-covid-shot-data-every-single?utm_source=post-email-title&publication_id=548354&post_id=174886252&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email

0 · Reply

tomorrow_coin Sep. 29 at 11:05 PM

$BNTX Timmmmmbbbbeeeerrrrrr……….. $STOCKTWITS

0 · Reply

Market Cap	25.28B
Revenue (ttm)	2.98B
Net Income (ttm)	-719.92M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-24.18%
Debt to Equity Ratio	0.01

Volume	704,300
Avg Vol	949,806
Day's Range	N/A - N/A
Shares Out	240.40M
Stochastic %K	89%
Beta	1.45
Analysts	Strong Sell
Price Target	$135.69